Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>Resources>Application Notes>This Application Note
  Application Notes
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Alzheimer’s Protein Serves as Natural Antibiotic
Alzheimer's-associated amyloid plaques may be part of natural process to trap microbes, findings suggest new therapeutic strategies.
Vitamin A May Help Improve Pancreatic Cancer Chemotherapy
The addition of high doses of a form of vitamin A could help make chemotherapy more successful in treating pancreatic cancer, according to an early study by Queen Mary University of London (QMUL).
Breakthrough Approach to Breast Cancer Treatment
Scripps scientists have designed a drug candidate that decreases growth of breast cancer cells.
Non-Toxic Approach to Treating Variety of Cancers
A team of researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine recently discovered a novel, non-toxic approach to treating a wide variety of cancers.
Making Injectable Medicine Safer
Researchers remove excess additives from drugs, which could reduce the odds of serious allergic reactions and other side effects.
An Old-New Weapon Against Emerging Chikungunya Virus
Researchers utilize existing drugs to interfere with host factors required for replication of Chikungunya virus.
Brazilian Zika Virus Strain Causes Birth Defects in Experimental Models
First direct experimental proof of causal effect, researchers say.
'Kidney on a Chip' Facilitates Safer Drug Dosing
University of Michigan researchers have used a "kidney on a chip" device to mimic the flow of medication through human kidneys and measure its effect on kidney cells.
Ketamine Metabolism Lifts Depression
NIH-funded team finds rapid-acting, non-addicting agent in mouse study.
Scroll Up
Scroll Down

Analysis of a New High Throughput Screening Detection Technology for Rapid hERG Safety Testing using a Fluorescence Polarization Assay
Bookmark and Share

Biotek Instruments

Background
Speed and sensitivity are the hallmarks of Fluorescence Polarization (FP) assay technologies. Due to this FP has seen penetration in the drug discovery and drug development markets for High Throughput Screening applications. For a good overview of applications/target audiences for FP here is an easy to read and interesting White Paper with good citations for further reading: Fluorescence Polarization in Life Sciences. The Predictor hERG biochemical FP assay has been used as a model of FP performance validation used on our Synergy lines, not only because it is an assay designed for HTS run at low volume in 384-well plates, but because quantification of hERG channel binding and inhibition are cardio toxicity tests recommended for all drug compounds before human use (e.g. in pre-clinical trials). Therefore, the assay needs to prove it can compare with GLP-compliant gold standard methods, and the detection technology used to produce that data must be rigorous enough to do the same. Although BioTek has published a number of pieces of marketing collateral using the Predictor hERG assay, until Synergy Neo, other Synergy models could only provide sensitivity acceptable for detection of this assay at the cost of speed. Publication of optimal read parameters was either largely ignored or minimized in the other BioTek collateral for this reason, as the combination of assay and detection parameters required for optimal data were largely prohibitory for HTS applications when competitors could do it at ~ 2 min plate read time within a 2 hour assay incubation window.

Further Information

Related Content

BioTek Instruments and Global Cell Solutions set to Collaborate
BioTek Instruments, Inc., and Global Cell Solutions, Inc., (GCS) announce a formal collaboration for the coming year at LabAutomation 2010. The poster Automation of a Microplate Cell-based Assay to Measure Activity of the Histamine H1 G Protein-coupled Receptor Using a Novel 3-D Cell Culture Technique is the first in a series of collaborative publications detailing the use of BioTek’s microplate instrumentation for various cell-based assays.
Wednesday, January 27, 2010
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!